Research / ECVT / Fundamental state Inspectable configuration
State dimensions Filing 0001708035-24-000070 General Corporate
Debt relative to revenue 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
125.59% · OPTIONAL · VALID
Capex intensity 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
9.45% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.91% · OPTIONAL · VALID
Revenue growth 42th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
-15.73% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
6.53% · OPTIONAL · VALID
Gross margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
28.64% · CORE · VALID
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.98% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.13% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.32% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 501.75%
Current 125.59%
Delta -376.17% Capex Intensity Increased
Previous 8.32%
Current 9.45%
Delta 1.14% Cash Generation Increased
Previous 18.62%
Current 19.91%
Delta 1.29% Growth Increased
Previous -25.46%
Current -15.73%
Delta 9.73% Inventory Pressure Decreased
Previous 27.85%
Current 6.53%
Delta -21.32% Margin Decreased
Previous 30.68%
Current 28.64%
Delta -2.04% Profitability Decreased
Previous 18.42%
Current 13.98%
Delta -4.44% Sbc Intensity Increased
Previous 2.01%
Current 2.32%
Delta 0.31% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.